deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT02631499

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Post-hepatectomy Adjuvant Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Preoperative CTC Level ≥2: a Multicenter Randomized Controlled Trial in China

Sponsor: Fudan University

Conditions Carcinoma, Hepatocellular Neoplastic Cells, Circulating
Interventions Epirubicin TACE lipiodol
Updated 8 times since 2017 Last updated: Dec 20, 2015 Started: Dec 31, 2015 Primary completion: Dec 31, 2018 Completion: Dec 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Carcinoma, Hepatocellular and Neoplastic Cells, Circulating, this trial is ongoing. The trial is conducted by Fudan University and has accumulated 8 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Jan 2020 · 19 months · monthly snapshotNot Yet Recruiting~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  5. Jan 2020 — Jan 2021 [monthly]

    Unknown Status PHASE4

    Status: Not Yet Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2020 [monthly]

    Not Yet Recruiting PHASE4

  2. Feb 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

  3. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fudan University
  • Johnson & Johnson Medical, China
  • Shanghai Zhongshan Hospital
Data source: Fudan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations